DURECT Corporation Reports Third Quarter 2022 Financial Results and Update of Programs
Nov 02, 2022, 16:05 ET – Webcast of Earnings Call Today, November 2nd at 4:30 p.m. ET – AHFIRM trial timeline continues to improve CUPERTINO, Calif., Nov. 2, 2022 /PRNewswire / — DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended September 30, 2022 and provided a corporate update. “We are […]
DURECT Corporation Reports Third Quarter 2022 Financial Results and Update of Programs Read More »